Title for MeetingAbstracts
Alphabetical listing of titles
Prolonged sensitivity of HIV-1 isolates to atevirdine (ATV) in a phase 1 clinical trial of ATV and zidovudine (ZDV) (ACTG 199). The ACTG 199 Study Team.
Prolonged successful therapy with Nelfinavir in inner city women.
Prolonged suppression of HIV-1 viremia results in profound but incomplete enhancement of anti-HIV-1 CTLm responses in advanced infection.
Prolonged suppression of plasma viremia results in progressive improvement in immune function despite possible immunosuppressive effects of protease inhibitors.
Prolonged Survival after HAART in AIDS-Associated Progressive Multifocal Leukoencephalopathy (PML).
Prolonged survival after highly active antiretroviral therapy (HAART) in AIDS-associated visceral leishmaniasis.
Prolonged survival of an AIDS patient with cytomegalovirus colonic vasculitis treated with ganciclovir.
Prolonged survival of end-stage AIDS patients receiving V-1 Immunitor.
Prolonged treatment interruption after immunologic response to HAART.
Promace Cytabon therapy for HIV+ related non Hodgkin's lymphoma (NHL).
PROMINENCE OF HLA-C-RESTRICTED CTL ACTIVITY IN THE HIV-SPECIFIC RESPONSE IN CLADE C INFECTED AFRICAN ZULU/XHOSA IN DURBAN.
Promiscuity of cytotoxic T-cell epitopes from the HIV-1 envelope.
Promiscuity: what does it means?
Promiscuous binding of viral CTL epitopes: an approach to refine HLA supertypes and to identify HIV CTL epitopes shared by HLA class I alleles differentially associated with slow or fast HIV disease progression.
Promiscuous CTL: a direct cause of CD4 T cell reduction in HIV-1 pathogenesis?
Promiscuous incontinence (Sexual High Risk Behavior) in post exposure period of HIV positive patient attending the STD clinic at red light area of MMC.
Promiscuous presentation of the same epitopes by different HLA class II alleles and clustering of overlapping but distinct epitopes both contribute to the high frequency of recognition by CD4 cells of a limited subset of Gag and Nef HIV-1 peptides.
Promiscuous Resistance Plasmids of Gram-Negative Bacteria.
Promises and pitfalls in systematic reviews on risk factors for musculoskeletal pain.
Promises and pitfalls of the Global Fund to Fight AIDS, Tuberculosis, and Malaria (GF): donor country funding, prioritization of HIV treatment, and the involvement of people living with HIV/AIDS (PLWHA).
Promises in the plague: The passage of the Ryan White CARE act as a case study for legislative action.
Promising experiences in mobilising the community toward the care taking of HIV/AIDS Orphans and Vulnerable Children (OVC). The case of Komtoega village in Burkina Faso.
Promote HIV/AIDS prevention education to rural Native Americans.
Promote the participation of the youth in the battle against HIV/AIDS and others STDs in the education institutions in Togo.
Promoter Analysis of Early Response Genes Induced by Chemokine Receptor Signaling.
Promoting "HIV-prevention in doctor's office".
Promoting a comprehensive response to STI/HIV/AIDS and youth pregnancy in the context of internal displacement in Colombia.
Promoting a self-help program for HIV+ people.
Promoting a wide social response to the HIV/AIDS epidemic in 5 Garifuna communities of the north coast of Honduras.
Promoting abstinence for AIDS control in the Uganda youth.